Resmed (RMD) Free Cash Flow Growth (3y) (2012 - 2026)
Powered by 
Analysis
Resmed (RMD) Free Cash Flow Growth (3y) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 177.43 Bn | 172.48 Bn | 7.27 Bn | 41.96% |
| 2 | Intuitive Surgical | 139.20 Bn | 134.11 Bn | 1.96 Bn | 24.84% |
| 3 | Medtronic | 118.01 Bn | 109.81 Bn | 6.34 Bn | 35.29% |
| 4 | Stryker | 105.44 Bn | 101.96 Bn | 4.50 Bn | 25.48% |
| 5 | Boston Scientific | 62.90 Bn | 62.60 Bn | 3.85 Bn | 35.42% |
| 6 | Edwards Lifesciences | 50.87 Bn | 46.72 Bn | 1.35 Bn | 250.09% |
| 7 | Dexcom | 33.72 Bn | 31.77 Bn | 830.00 Mn | 12.01% |
| 8 | Resmed | 32.45 Bn | 30.98 Bn | 861.22 Mn | 25.74% |
| 9 | Alcon | 31.70 Bn | 30.25 Bn | 1.68 Bn | 11.09% |
| 10 | Steris | 20.01 Bn | 19.54 Bn | 684.20 Mn | 9.23% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 25.74% |
| Mar 31, 2026 | 27.06% |
| Dec 31, 2025 | 45.38% |
| Sep 30, 2025 | 198.33% |
| Jun 30, 2025 | 115.41% |
| Mar 31, 2025 | 100.71% |
| Dec 31, 2024 | 14.98% |
| Sep 30, 2024 | 74.45% |
| Jun 30, 2024 | 27.87% |
| Mar 31, 2024 | 30.87% |
| Dec 31, 2023 | 22.72% |
| Sep 30, 2023 | 25.22% |
| Jun 30, 2023 | -13.38% |
| Mar 31, 2023 | 6.49% |
| Dec 31, 2022 | 31.22% |
| Sep 30, 2022 | -51.84% |
| Jun 30, 2022 | -24.81% |
| Mar 31, 2022 | -17.88% |
| Dec 31, 2021 | 19.50% |
| Sep 30, 2021 | -66.88% |